Crewe Advisors’s Adaptive Biotechnologies ADPT Stock Holding History

Crewe Advisors’s Portfolio ADPT Stock Details ADPT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$248K	Hold	11,543	–	–	0.02%	211
2026 Q1	$160K	Hold	11,543	–	–	0.01%	228
2025 Q4	$187K	Hold	11,543	–	–	0.02%	211
2025 Q3	$173K	Hold	11,543	–	–	0.02%	228
2025 Q2	$134K	Hold	11,543	–	–	0.02%	193
2025 Q1	$85.8K	Hold	11,543	–	–	0.01%	215
2024 Q4	$69.2K	Hold	11,543	–	–	0.01%	250
2024 Q3	$59.1K	Sell	11,543 -47,595	-80%	-$207K	0.01%	281
2024 Q2	$214K	Hold	59,138	–	–	0.02%	173
2024 Q1	$190K	Sell	59,138 -600	-1%	-$2.32K	0.02%	174
2023 Q4	$293K	Hold	59,738	–	–	0.05%	60
2023 Q3	$326K	Hold	59,738	–	–	0.06%	59
2023 Q2	$401K	Hold	59,738	–	–	0.06%	89
2023 Q1	$527K	Hold	59,738	–	–	0.08%	81
2022 Q4	$456K	Sell	59,738 -113	-0.2%	-$879	0.07%	83
2022 Q3	$426K	Hold	59,851	–	–	0.08%	82
2022 Q2	$484K	Buy	59,851 +613	+1%	+$5.39K	0.11%	60
2022 Q1	$822K	Buy	59,238 +100	+0.2%	+$1.57K	0.16%	34
2021 Q4	$1.66M	Hold	59,138	–	–	0.34%	24
2021 Q3	$2.01M	Hold	59,138	–	–	0.48%	18
2021 Q2	$2.42M	Hold	59,138	–	–	0.6%	17
2021 Q1	$2.38M	Hold	59,138	–	–	0.59%	18
2020 Q4	$3.5M	Sell	59,138 -16,870	-22%	-$870K	1.4%	17
2020 Q3	$3.7M	Sell	76,008 -5,410	-7%	-$227K	1.73%	13
2020 Q2	$3.94M	Sell	81,418 -11,582	-12%	-$422K	1.92%	11
2020 Q1	$2.58M	Buy	+93,000	New	+$2.59M	1.54%	13

Other funds holding ADPT

Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Crewe Advisors's ADPT Position: Q2 2026 in Review

Crewe Advisors held its Adaptive Biotechnologies (ADPT) position steady in Q2 2026 at 11,543 shares worth $248K. The position accounts for 0.02% of the portfolio, ranked #211.

Crewe Advisors first reported a position in ADPT in Q1 2020 and has held it in 26 quarters since. The position peaked at $3.94M in Q2 2020. 300 funds tracked by Wall St. Rank hold ADPT as of Q2 2026.

Crewe Advisors held 11,543 shares of Adaptive Biotechnologies worth $248K as of Q2 2026.
Crewe Advisors left its Adaptive Biotechnologies share count unchanged in Q2 2026.
Adaptive Biotechnologies made up 0.02% of Crewe Advisors's portfolio in Q2 2026, its #211 holding.
Crewe Advisors first reported a position in Adaptive Biotechnologies in Q1 2020 and has held it in 26 quarters since.
Crewe Advisors's Adaptive Biotechnologies position peaked at $3.94M in Q2 2020.
300 funds tracked by Wall St. Rank held Adaptive Biotechnologies as of Q2 2026.

Based on Crewe Advisors's 13F filing for Q2 2026, filed 24 Jul 2026.